IT'S ALL IN THE NAME LTD

Executive Summary

IT'S ALL IN THE NAME LTD is currently facing financial challenges characterized by a working capital deficit and negative equity, signaling operational strain and accumulated losses. The company’s liquidity situation requires urgent attention, and a strategic financial overhaul including capital injection, improved cash flow management, and governance restructuring is recommended to stabilize and improve its financial wellness.

View Full Analysis Report →

Company Analysis

This analysis is opinion only and should not be interpreted as financial advice.

IT'S ALL IN THE NAME LTD - Analysis Report

Company Number: 14130350

Analysis Date: 2025-07-29 12:32 UTC

Financial Health Assessment: IT'S ALL IN THE NAME LTD


1. Financial Health Score: D

Explanation:
The company exhibits signs of financial strain and fragility. Negative net current assets (working capital deficit) over consecutive years, combined with negative shareholders’ funds, indicate a weak financial condition. While not immediately critical, these symptoms suggest the company is under financial distress and needs remedial action to stabilize.


2. Key Vital Signs

Metric 2024 (£) 2023 (£) Interpretation
Current Assets 51,445 38,378 Increased cash and receivables—positive liquidity sign
Current Liabilities 53,163 39,108 Growing short-term debts—pressure on cash flow
Net Current Assets -1,718 -730 Working capital deficit—company may struggle to meet short-term obligations
Shareholders’ Funds (Equity) -1,718 -730 Negative equity—indicates accumulated losses or liabilities exceeding assets
  • Working Capital Deficit: The company consistently has more short-term liabilities than assets, meaning it may face challenges paying bills on time.
  • Negative Shareholders’ Funds: Reflects accumulated losses or insufficient capital, undermining financial stability.
  • Cash Position: Cash increased from £21,880 in 2023 to a higher current assets figure in 2024, but still insufficient to cover liabilities.
  • Micro Entity Status: The company’s small size limits filing requirements but also means limited financial cushion.

3. Diagnosis: Signs of Financial Distress

The company is exhibiting symptoms akin to a patient with a chronic condition:

  • "Working Capital Deficiency" is like a heart struggling to pump sufficient blood; the company’s day-to-day liquidity is weak, risking operational hiccups.
  • "Negative Equity" signals a weakened immune system—accumulated losses are eating into the company’s net worth, which may hinder future borrowing or investment.
  • The increasing current liabilities outpacing current assets suggest the company is relying on short-term credit, which if unchecked, may lead to insolvency risk.
  • The company has a very small workforce (1 employee), indicating limited operational scale.
  • Recent change in director and control may reflect ongoing restructuring or attempts to address governance issues.
  • The absence of audit requirements for micro-entities implies limited external scrutiny, which can mask deeper issues.

Overall, the company's "vital signs" show a patient in mild to moderate distress, requiring intervention to prevent deterioration.


4. Recommendations: Treatment Plan for Financial Wellness

To improve financial health, the company should consider the following steps:

a. Improve Liquidity and Working Capital Management

  • Tighten credit control and accelerate receivables collection.
  • Negotiate longer payment terms with suppliers to ease cash flow pressure.
  • Review and reduce unnecessary expenses to conserve cash.

b. Capital Injection

  • Consider fresh equity funding or loans from shareholders or external investors to restore positive net assets.
  • Explore government support schemes for micro businesses if applicable.

c. Financial Restructuring

  • Evaluate liabilities for potential refinancing or restructuring, possibly extending payment terms or consolidating debt.
  • Implement rigorous budgeting and cash flow forecasting to anticipate and manage shortfalls.

d. Governance and Strategic Review

  • With the recent director change, ensure clear strategic direction focusing on sustainable growth.
  • Seek professional financial advice to establish financial controls and reporting systems.

e. Monitor Financial Health Regularly

  • Establish key performance indicators (KPIs) such as current ratio, quick ratio, and cash runway.
  • Schedule regular financial reviews to detect early symptoms of distress.

In medical terms, the company is showing early symptoms of financial distress but is not yet critically ill. With timely intervention and treatment, there is a good chance of recovery and restoration of financial health.



More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company